Position in NTRA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,589,090
+$1,020,769 QoQ
Shares Held
9,538
+21.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#337
of 844 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Ninepoint Partners LP holds $5,442,360 across 2 Diagnostics & Research names. NTRA ranks #2 (47.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
19,018 | $2,853,270 | |
| 2 | NTRA |
Natera, Inc.
This page
|
9,538 | $2,589,090 |
All Filings in NTRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,589,090 | 9,538 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,568,321 | 7,842 | Shares | Sole | 2026-08-11 | |
| 2025-12-31 | $624,499 | 2,726 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $220,206 | 1,368 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||